MOLE', Daniela
 Distribuzione geografica
Continente #
NA - Nord America 3.109
AS - Asia 1.607
EU - Europa 1.174
SA - Sud America 279
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.215
Nazione #
US - Stati Uniti d'America 3.056
SG - Singapore 591
CN - Cina 431
FR - Francia 213
BR - Brasile 210
DE - Germania 193
VN - Vietnam 189
UA - Ucraina 166
PL - Polonia 143
HK - Hong Kong 123
IT - Italia 120
GB - Regno Unito 97
TR - Turchia 97
FI - Finlandia 94
SE - Svezia 50
JP - Giappone 45
RU - Federazione Russa 43
BD - Bangladesh 32
IN - India 31
CA - Canada 27
AR - Argentina 23
MX - Messico 18
ZA - Sudafrica 17
IQ - Iraq 13
EC - Ecuador 12
ID - Indonesia 11
NL - Olanda 11
ES - Italia 9
VE - Venezuela 9
CO - Colombia 8
LT - Lituania 8
UZ - Uzbekistan 8
CL - Cile 7
PK - Pakistan 7
AT - Austria 6
BE - Belgio 6
KE - Kenya 6
TN - Tunisia 5
IE - Irlanda 4
JO - Giordania 4
PY - Paraguay 4
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
MA - Marocco 2
OM - Oman 2
PE - Perù 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
ML - Mali 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.215
Città #
Ashburn 399
Singapore 398
Woodbridge 268
Chandler 205
San Jose 200
Fairfield 199
Jacksonville 186
Houston 169
Warsaw 143
Santa Clara 142
Beijing 136
Ann Arbor 132
Hong Kong 120
Wilmington 85
Seattle 77
Cambridge 65
Ho Chi Minh City 63
Los Angeles 56
Munich 56
Addison 52
Tokyo 45
Hanoi 44
Nanjing 44
Izmir 42
New York 42
Helsinki 35
Princeton 35
Boardman 32
Lauterbourg 31
Dallas 30
Shanghai 26
Turku 26
Dearborn 25
Ferrara 25
São Paulo 24
Milan 23
Buffalo 21
Bremen 20
San Diego 17
Shenyang 17
Jinan 15
Nuremberg 15
Atlanta 13
Brooklyn 13
Denver 13
Frankfurt am Main 13
Johannesburg 13
Mountain View 13
Nanchang 12
Chennai 11
Da Nang 11
London 11
Orem 11
Tianjin 11
Washington 11
Manchester 10
Mexico City 10
Rome 10
Haiphong 9
Montreal 9
Chicago 8
Hebei 8
Jiaxing 8
L’Aquila 8
Poplar 8
Auburn Hills 7
Changsha 7
Moscow 7
Tashkent 7
Brussels 6
Guayaquil 6
Jakarta 6
Newark 6
Norwalk 6
Orange 6
Rio de Janeiro 6
Stockholm 6
Amsterdam 5
Baghdad 5
Boston 5
Brasília 5
Caracas 5
Dhaka 5
Guangzhou 5
Hefei 5
Hải Dương 5
Indiana 5
Nairobi 5
New Delhi 5
Amman 4
Ankara 4
Augusta 4
Cagliari 4
Catalão 4
Charlotte 4
Curitiba 4
Dublin 4
Medellín 4
Ningbo 4
Osasco 4
Totale 4.209
Nome #
PKC COME NUOVO TARGET MOLECOLARE NEL CONTROLLO DELLA PROLIFERAZIONE CELLULARE DEI TUMORI NEUROENDOCRINI 413
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 253
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 233
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 220
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Growth hormone excess promotes breast cancer chemoresistance 211
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 210
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 202
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 200
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 189
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 187
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 186
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 186
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 182
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 181
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 180
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 178
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 177
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 172
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 171
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 164
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 160
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 157
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 152
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 145
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 143
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 142
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 130
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 119
Targeting PKC in human pancreatic neuroendocrine tumor cells 117
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 117
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  109
null 40
Totale 6.245
Categoria #
all - tutte 24.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022313 13 28 15 3 13 18 10 8 8 34 43 120
2022/2023422 39 39 20 55 77 52 19 36 57 0 15 13
2023/2024252 21 22 11 9 16 41 9 77 3 3 2 38
2024/2025863 22 19 58 18 122 125 25 18 100 95 124 137
2025/20262.368 205 104 173 282 452 249 292 97 212 212 80 10
Totale 6.245